Idenix news shows hep C drug market increasingly murky for investors
April 08, 2014 at 14:50 PM EDT
In the cutthroat hepatitis C drug market — the recent focus of a slew of biotechs, both big and small — investors seem to be increasingly unsure what constitutes good news...